NASDAQ:KALA
Kala Pharmaceuticals Inc Stock News
$6.55
-0.180 (-2.67%)
At Close: May 17, 2024
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
04:01pm, Friday, 18'th Jun 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Comp
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript
01:31pm, Wednesday, 05'th May 2021
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2021 Results - Earnings Call Transcript
Kala Pharmaceuticals (KALA) Reports Q1 Loss, Misses Revenue Estimates
09:24am, Wednesday, 05'th May 2021
Kala Pharma (KALA) delivered earnings and revenue surprises of 3.92% and -10.28%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
07:01am, Wednesday, 05'th May 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for disease
Kala Pharmaceuticals Has Good Short- And Long-Term Prospects
02:07am, Sunday, 25'th Apr 2021
Kala Pharmaceuticals' Eysuvis, a corticosteroid-based drug, was approved for both signs and symptoms of dry eye disease last year and sale calls began on Jan 4th 2021. The market uptake of Eysuvis has
Kala Pharmaceuticals: Eye Treatment Specialist With Much To Prove May Have Just The Product
03:52pm, Saturday, 24'th Apr 2021
Kala Pharmaceuticals has had a torrid time growing sales of its first approved ocular therapy Inveltys, for postoperative pain, which earned just $6.1m in FY20. In October last year, Kala won approval
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
08:00am, Tuesday, 02'nd Mar 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for disease
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript
02:12pm, Thursday, 25'th Feb 2021
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q4 2020 Results - Earnings Call Transcript
Kala Pharmaceuticals (KALA) Reports Q4 Loss, Lags Revenue Estimates
09:09am, Thursday, 25'th Feb 2021
Kala Pharma (KALA) delivered earnings and revenue surprises of -19.57% and -6.44%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
08:00am, Thursday, 18'th Feb 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for disease
Kala Pharmaceuticals (KALA) Expected to Beat Earnings Estimates: Should You Buy?
01:39pm, Wednesday, 03'rd Feb 2021
Kala Pharma (KALA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
04:01pm, Wednesday, 20'th Jan 2021
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Comp
Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved
08:24pm, Tuesday, 22'nd Dec 2020
Kala Pharmaceuticals Should Have Limited Downside With Eysuvis Now Approved
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
04:01pm, Friday, 18'th Dec 2020
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Comp
The Play On Kala Pharmaceuticals
02:03am, Thursday, 17'th Dec 2020
The Play On Kala Pharmaceuticals
